Saturday, December 5, 2020
Home Climate411 “Remdesivir for COVID-19” Study accidentally proved effectiveness of Hydroxychloroquine

“Remdesivir for COVID-19” Study accidentally proved effectiveness of Hydroxychloroquine

-

The use of Remdesivir for COVID-19 was authorized by the FDA based on a single RCT, conducted by NIAID with the participation of Gilead Sciences, the exclusive manufacturer of Remdesivir. A final report from this study was published on October 8, five months after the drug’s authorization.

- Advertisment -

Related Articles

Preventing Ecosystem Collapse: Alaska’s Kelp Forests

Although these biological interactions control ecosystem shifts between kelp forests and urchin barrens, climate factors play a role, and in a most positive way....

Aussie Brown Coal to Clean Hydrogen Plant will Address Carbon Capture “Eventually”

Proponents are celebrating Kawasaki Heavy Industry's planned construction of a coal to hydrogen plant in Victoria, which is intended to prove the viability of...

Biden Promises to Request 100 Days of Mask Wearing to Combat Covid-19

Joe Biden has called for 100 days where everyone has to wear a mask. But Biden has not clarified whether this mandate will apply...